BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Genomic Health, Inc. 

301 Penobscot Drive

Redwood City  California  94063  U.S.A.
Phone: 650-556-9300 Fax: 650-556-1132


SEARCH JOBS



Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions. With half a million patients tested in more than 70 countries, the Oncotype DX tests have redefined personalized medicine by making genomics a critical part of cancer diagnosis and treatment. Based in Redwood City, Calif. with European headquarters in Geneva, Switzerland, the company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey.


 Key Statistics


Email:
Ownership: Public

Web Site: Genomic Health, Inc.
Employees:
Symbol: GHDX
 



Industry
Medical Device






 Company News
Genomic Health, Inc. (GHDX): New Oncotype DX® Data Presented At 2014 San Antonio Breast Cancer Symposium Further Demonstrate The Practice-Changing Impact Of The Test In Guiding The Treatment Of Early Stage Breast Cancer 12/15/2014 10:12:45 AM
Genomic Health, Inc. (GHDX) Release: Oncotype DX DCIS Score Represents Breakthrough In Personalizing Treatment Of Pre-Invasive Breast Cancer 12/12/2014 8:07:14 AM
Genomic Health, Inc. (GHDX) Announces Presentation Of First Prospective Outcomes Study Of Oncotype DX Breast Cancer Test 12/10/2014 8:35:17 AM
Genomic Health, Inc. (GHDX) Advances Development Of Novel Liquid Biopsy-Based Cancer Tests 12/9/2014 11:29:32 AM
Genomic Health, Inc. (GHDX) Release: Oncotype DX Predicts Outcomes In Prostate Cancer Patients, Significantly Changes Treatment Recommendations 12/3/2014 11:51:26 AM
Genomic Health, Inc. (GHDX) To Present At The 26th Annual Piper Jaffray Healthcare Conference 12/1/2014 3:50:35 PM
Genomic Health, Inc. (GHDX) Release: Results from Second Oncotype DX Prostate Cancer Test Clinical Validation And First Decision Impact Study To Be Published In European Urology And Urology Practice, Respectively 11/19/2014 12:26:52 PM
Genomic Health, Inc. (GHDX) Announces Third Quarter 2014 Financial Results And Reports Continued Growth In U.S. Invasive Breast Cancer Business 11/5/2014 7:36:08 AM
Genomic Health, Inc. (GHDX) To Present At The Credit Suisse Annual Healthcare Conference 11/4/2014 9:07:29 AM
Genomic Health, Inc. (GHDX) To Announce Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 4, 2014 10/28/2014 7:59:26 AM
12345678910...